Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
DCGO
#3385
DocGo Inc. Common Stock
0.7
2
+4.35%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+4.35%
Changement Mensuel
-18.18%
Evolution sur 6 mois
-55.83%
Changement Annuel
-75.17%
Clôture Précédente
0.6
9
Open
0.7
2
Bid
Ask
Low
0.7
2
High
0.7
2
Volume
84
Marchés
Actions des Marchés US
Soins de Santé
DCGO
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Total assets
493.88 M
455.62 M
430.79 M
408.26 M
353.78 M
Total liabilities
168.98 M
140.44 M
128.87 M
120.53 M
93.12 M
Total equity
324.9 M
315.18 M
301.92 M
287.73 M
260.66 M
Total liabilities & shareholders' equities
493.88 M
455.62 M
430.79 M
408.26 M
353.78 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
DocGo Inc
DocGo is a mobile healthcare company founded in 2015 as Ambulnz, and is now traded on the NASDAQ. The company specializes in mobile health services and medical transportation.
Nouvelles
DocGo receives Nasdaq notice for minimum bid price non-compliance
DocGo’s SteadyMD to expand clinical staff by up to 50% amid GLP-1 demand
DocGo stock repurchase program extended by board to June 2026
DocGo extends share repurchase program expiration to June 2026
DocGo at 17th Annual Southwest IDEAS Conference: Strategic Shift in Focus
DocGo stock price target lowered to $1.50 by Canaccord Genuity
Stifel maintains Buy rating on DocGo stock amid migrant contract wind-down
DocGo stock rating reiterated by Cantor Fitzgerald on growth potential
DocGo Inc. (DCGO) Q3 2025 Earnings Call Transcript
Earnings call transcript: DocGo’s Q3 2025 sees revenue drop, misses EPS forecast
DocGo Inc. (DCGO) Reports Q3 Loss, Beats Revenue Estimates
DocGo earnings missed by $0.16, revenue topped estimates